ALBANY MOLECULAR RESH INC's ticker is AMRI and the CUSIP is 012423109. A total of 120 filers reported holding ALBANY MOLECULAR RESH INC in Q4 2013. The put-call ratio across all filers is 0.88 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $3,983,000 | -49.0% | 260,479 | -31.6% | 0.01% | -50.0% |
| Q4 2015 | $7,810,000 | +11.3% | 380,960 | -5.5% | 0.01% | +7.7% |
| Q3 2015 | $7,019,000 | -28.2% | 402,933 | -16.6% | 0.01% | -18.8% |
| Q2 2015 | $9,771,000 | +63.0% | 483,201 | +41.9% | 0.02% | +45.5% |
| Q1 2015 | $5,994,000 | -7.8% | 340,585 | -16.9% | 0.01% | 0.0% |
| Q4 2014 | $6,502,000 | -47.6% | 409,768 | -27.1% | 0.01% | -50.0% |
| Q3 2014 | $12,402,000 | +8.9% | 561,915 | -0.8% | 0.02% | +10.0% |
| Q2 2014 | $11,392,000 | +47.4% | 566,213 | +17.4% | 0.02% | +42.9% |
| Q1 2014 | $7,731,000 | +266.4% | 482,252 | +147.1% | 0.01% | +250.0% |
| Q4 2013 | $2,110,000 | -51.5% | 195,157 | -42.2% | 0.00% | -50.0% |
| Q3 2013 | $4,349,000 | -14.1% | 337,432 | -20.9% | 0.01% | -11.1% |
| Q2 2013 | $5,063,000 | – | 426,606 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 567,400 | $11,473,000 | 12.05% |
| Permian Investment Partners, LP | 1,875,650 | $37,926,000 | 7.67% |
| OBERMEYER WOOD INVESTMENT COUNSEL, LLLP | 1,490,174 | $30,131,000 | 2.57% |
| AMERICAN CAPITAL MANAGEMENT INC | 993,280 | $20,084,000 | 1.91% |
| Netols Asset Management, Inc. | 387,471 | $7,835,000 | 1.54% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,158,759 | $23,430,000 | 1.35% |
| Evercore Wealth Management, LLC | 1,233,880 | $24,948,000 | 1.13% |
| Visium Asset Management, LP | 3,200,000 | $64,704,000 | 0.92% |
| Granite Investment Partners, LLC | 303,787 | $6,143,000 | 0.57% |
| FRANKLIN STREET ADVISORS INC /NC | 144,125 | $2,914,000 | 0.52% |